Specialty Pharmacy Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Brand | Generic | Basic Info |
Cosentxy | secukinumab | MOA: IL-17 inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis Administration(general): SubQ, Monthly Unique ADES: IBD exacerbation/new onset |
Enbrel | etanercept | MOA: TNF inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis,RA,JIA Administration(general): SubQ, weekly Unique ADEs: Cardiac,CNS Biosimilar: Erelzi |
Humira | adalimumab | MOA: TNF inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis,RA, IBD,JIA,+ Administration(general):SubQ, Q2 Week Unique ADEs: Cardiac,CNS Biosimilars:Amjevita and Cyltezo |
Otezla | aprimilast | MOA: PDE-4 inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis Administration(general): PO, BID Unique ADEs: GI (severe), Psych Titration pack available |
Remicade | infliximab | MOA: TNF inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis,RA,IBD,JIA,+ Administration(general): IV, Q2 month Unique ADEs: Cardiovascular, CNS, infusion reaction (premedicate) Biosimilars: Renflexis, Inflectra |
Siliq | brodalumab | MOA: IL-17 inhibitor Indications: Plaque Psoriasis Administration(general): SubQ, Q2 week Unique ADEs: Suicidal Ideation (BBW and REMS), IBD exacerbation/new onset |
Stelara | ustekinumab | MOA: IL-12,23 inhibitor Indications: Plaque Psoriasis, Psoriatic Arthritis,IBD Administration(general):SubQ, Q3 months Unique ADEs: Neurotoxicity (RPLS) |
Taltz | ixekizumab | MOA: IL-17 inhibitor Indications: Plaque Psoriasis Administration(general): SubQ, Monthly Unique ADES: IBD exacerbation/new onset |
Tremfya | guselkumab | MOA: IL-23 inhibitor Indications: Plaque Psoriasis Administration(general): SubQ, Q2 months |
Cimzia | certolizumab | MOA: TNF inhibitor Indications:, Psoriatic Arthritis,RA, IBD,+ Administration(general): SubQ, monthly Unique ADEs: Anemias, CNS, Cardiac |
Simponi | golimumab | MOA: TNF inhibitor Indications:Psoriatic Arthritis,RA, IBD,+ Administration(general):SubQ,monthly Unique ADEs: Anemias, CNS, Cardiac |
Actemra | tocilzumab | MOA: IL-6 inhibitor Indications: RA Administration(general): SUbQ, Weekly |
Kineret | anakinra | MOA: IL-1 inhibitor Indications: RA, + Administration(general): SubQ,daily Unique ADEs: Neuotrophilia(SEVERE) monitor monthly x 3 months, then q3months |
Orencia | abatacept | MOA: T-cell costim-blocker Indications: Psoriatic Arthritis,RA Administration(general):SubQ, weekly Unique ADEs: Worse outcomes in COPD patients |
Xeljanx | tofactinib | MOA: JAK STAT inhibitor Indications: RA,IBD Administration(general):PO, BID (QD for XR) Unique ADES: Bradycard/arrythmia, anemias(dose adjust),liver injury(monitor),lipids (monitor) Renal and Hepatic Dosing- 5mg QD |
Entyvio | vedolizumab | MOA: CAM-1 inhibitor Indications: IBD Administration(general):IV, Q2 months Unique ADES: Liver injury, PML |
Inflammatory Conditions Generalizations: Methotrexate OKAY do NOT double up biologics TNF blockers 1st line biologics | Vaccinate before initiation: NO LIVE VACCINES during therapy. Avoid in Preg/BF Many also used for Ankylosing spondylitis | Warnings for: Infection, Malignancy TB testing, HepB/C, testing SubQ: Refrigerate, don't freeze or shake. Thigh,back of arm, abdomen(rotate) |
Created by:
Briovastudent
Popular Pharmacology sets